
Gilde Healthcare
Description
Gilde Healthcare is a specialized healthcare investor based in Utrecht, The Netherlands, with a strong focus on both later-stage venture capital and lower mid-market buyouts. The firm manages over €2 billion (approximately $2.1 billion) across its distinct fund strategies, positioning itself as a significant player in the European and North American healthcare investment landscape. Their investment approach is characterized by deep sector expertise and a commitment to fostering growth in their portfolio companies.
Their Venture & Growth strategy targets innovative companies developing novel therapeutics, diagnostics, medical devices, and digital health solutions. Within this arm, Gilde Healthcare typically participates in Series A and B funding rounds. Initial investments for venture deals generally range from €5 million to €15 million, with the capacity to invest up to €30 million over the lifecycle of a portfolio company. This approach supports high-growth businesses poised for significant market disruption, often requiring substantial capital to scale their innovations.
Complementing their venture activities, Gilde Healthcare's Private Equity strategy focuses on profitable, lower mid-market healthcare companies. This includes investments in healthcare providers, suppliers of medical products and services, and contract research organizations. For these private equity transactions, the firm typically deploys equity investments ranging from €10 million to €50 million per company. This dual-pronged strategy allows Gilde Healthcare to address a broad spectrum of opportunities across the healthcare value chain, from early innovation to established businesses seeking growth or consolidation.
The firm's robust capital base and clear investment focus enable it to provide substantial support to its portfolio companies. Gilde Healthcare's commitment to building sustainable value, combined with its strategic presence in key healthcare markets, underscores its influential role in the evolving global healthcare sector.
Investor Profile
Gilde Healthcare has backed more than 119 startups, with 12 new investments in the last 12 months alone. The firm has led 45 rounds, about 38% of its total and boasts 37 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States, The Netherlands, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 3 rounds in the past year.
- Typical check size: $5.4M – $53.6M.
Stage Focus
- Series B (22%)
- Series C (18%)
- Series A (17%)
- Series D (13%)
- Series Unknown (13%)
- Private Equity (8%)
- Series E (5%)
- Series F (2%)
- Seed (1%)
- Series G (1%)
Country Focus
- United States (34%)
- The Netherlands (18%)
- United Kingdom (9%)
- Denmark (8%)
- Germany (8%)
- Switzerland (6%)
- Ireland (5%)
- Belgium (4%)
- Spain (4%)
- France (3%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Medical Device
- Pharmaceutical
- Therapeutics
- Biopharma
- Health Diagnostics
- Life Science
- Genetics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.